These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction. Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556 [TBL] [Abstract][Full Text] [Related]
10. The assessment of the non-equilibrium effect in the 'Patlak analysis' of Fdopa PET studies. Yu DC; Huang SC; Barrio JR; Phelps ME Phys Med Biol; 1995 Jul; 40(7):1243-54. PubMed ID: 7568380 [TBL] [Abstract][Full Text] [Related]
11. Automated striatal uptake analysis of ¹⁸F-FDOPA PET images applied to Parkinson's disease patients. Chang IC; Lue KH; Hsieh HJ; Liu SH; Kao CH Ann Nucl Med; 2011 Dec; 25(10):796-803. PubMed ID: 21887536 [TBL] [Abstract][Full Text] [Related]
13. Extrastriatal mean regional uptake of fluorine-18-FDOPA in the normal aged brain--an approach using MRI-aided spatial normalization. Nagano AS; Ito K; Kato T; Arahata Y; Kachi T; Hatano K; Kawasumi Y; Nakamura A; Yamada T; Abe Y; Ishigaki T Neuroimage; 2000 Jun; 11(6 Pt 1):760-6. PubMed ID: 10860800 [TBL] [Abstract][Full Text] [Related]
14. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge. Vernaleken I; Kumakura Y; Cumming P; Buchholz HG; Siessmeier T; Stoeter P; Müller MJ; Bartenstein P; Gründer G Neuroimage; 2006 May; 30(4):1332-9. PubMed ID: 16439159 [TBL] [Abstract][Full Text] [Related]
15. 6-[18F]fluorodopa metabolism in patients with hemiparkinsonism studied by positron emission tomography. Nagasawa H; Saito H; Kogure K; Hatazawa J; Itoh M; Fujiwara T; Watanuki S; Seo S; Iwata R; Ido T J Neurol Sci; 1993 Apr; 115(2):136-43. PubMed ID: 8482975 [TBL] [Abstract][Full Text] [Related]
16. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study. Ma Y; Feigin A; Dhawan V; Fukuda M; Shi Q; Greene P; Breeze R; Fahn S; Freed C; Eidelberg D Ann Neurol; 2002 Nov; 52(5):628-34. PubMed ID: 12402261 [TBL] [Abstract][Full Text] [Related]
17. (18)F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment. Lizarraga KJ; Allen-Auerbach M; Czernin J; DeSalles AA; Yong WH; Phelps ME; Chen W J Nucl Med; 2014 Jan; 55(1):30-6. PubMed ID: 24167081 [TBL] [Abstract][Full Text] [Related]
18. Dual time point method for the quantification of irreversible tracer kinetics: A reference tissue approach applied to [ Lopes Alves I; Meles SK; Willemsen AT; Dierckx RA; Marques da Silva AM; Leenders KL; Koole M J Cereb Blood Flow Metab; 2017 Sep; 37(9):3124-3134. PubMed ID: 28156211 [TBL] [Abstract][Full Text] [Related]
19. Kinetics and modeling of L-6-[18F]fluoro-dopa in human positron emission tomographic studies. Huang SC; Yu DC; Barrio JR; Grafton S; Melega WP; Hoffman JM; Satyamurthy N; Mazziotta JC; Phelps ME J Cereb Blood Flow Metab; 1991 Nov; 11(6):898-913. PubMed ID: 1939385 [TBL] [Abstract][Full Text] [Related]
20. L-6-[18F]fluoro-dopa metabolism in monkeys and humans: biochemical parameters for the formulation of tracer kinetic models with positron emission tomography. Melega WP; Grafton ST; Huang SC; Satyamurthy N; Phelps ME; Barrio JR J Cereb Blood Flow Metab; 1991 Nov; 11(6):890-7. PubMed ID: 1939384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]